136 related articles for article (PubMed ID: 16755174)
21. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
22. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
Aydin D; Sendur MA; Kefeli U; Umut Unal O; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Bala Ustaalioglu B; Sener Dede D; Esbag O; Inal A; Bilir C; Bilici A; Harputlu H; Berk V; Sevinc A; Yildirim Ozdemir N; Yildirim E; Sonkaya A; Ali Ustaoglu M; Gumus M
J BUON; 2016; 21(5):1242-1249. PubMed ID: 27837629
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency.
Czaykowski P; Hui D
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):143-9. PubMed ID: 17355111
[TBL] [Abstract][Full Text] [Related]
25. [Treatment and outcome in small bowel cancer].
Ogata Y; Yamaguchi K; Sasatomi T; Uchida S; Akagi Y; Shirouzu K
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1454-7. PubMed ID: 20716869
[TBL] [Abstract][Full Text] [Related]
26. Management of small bowel adenocarcinoma.
Kummar S; Ciesielski TE; Fogarasi MC
Oncology (Williston Park); 2002 Oct; 16(10):1364-9; discussion 1370, 1372-3. PubMed ID: 12435206
[TBL] [Abstract][Full Text] [Related]
27. Small bowel adenocarcinoma: report of three cases and review of literature.
Haq MM; Blumenthal BJ; Culotta RJ; Cain DN; McCleery JM
Tex Med; 1985 Mar; 81(3):51-4. PubMed ID: 3885467
[No Abstract] [Full Text] [Related]
28. What are the latest pharmacotherapy options for small bowel adenocarcinoma?
Ynson ML; Senatore F; Dasanu CA
Expert Opin Pharmacother; 2014 Apr; 15(6):745-8. PubMed ID: 24588646
[TBL] [Abstract][Full Text] [Related]
29. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and Treatment Strategies for Small Bowel Adenocarcinoma in Advanced-stage Cases.
Nakanoko T; Koga T; Taketani K; Hirayama Y; Yoshiya S; Minagawa R; Kai M; Kajiyama K; Maehara Y
Anticancer Res; 2015 Jul; 35(7):4135-8. PubMed ID: 26124367
[TBL] [Abstract][Full Text] [Related]
31. Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis.
Nakazawa T; Narita Y; Kumanishi R; Ogata T; Matsubara Y; Nozawa K; Kato K; Honda K; Masuishi T; Bando H; Kadowaki S; Ando M; Hara K; Tajika M; Muro K
Anticancer Res; 2021 Oct; 41(10):5147-5155. PubMed ID: 34593466
[TBL] [Abstract][Full Text] [Related]
32. Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practice.
Legué LM; Bernards N; Lemmens VE; de Hingh IH; Creemers GJ; van Erning FN
United European Gastroenterol J; 2019 Dec; 7(10):1380-1388. PubMed ID: 31839964
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
Nishikawa Y; Hoshino N; Horimatsu T; Funakoshi T; Hida K; Sakai Y; Muto M; Nakayama T
Int J Clin Oncol; 2020 Aug; 25(8):1441-1449. PubMed ID: 32448950
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for primary adenocarcinoma of the small bowel.
Jigyasu D; Bedikian AY; Stroehlein JR
Cancer; 1984 Jan; 53(1):23-5. PubMed ID: 6690001
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Nutr Cancer; 2016 Jul; 68(5):750-5. PubMed ID: 27282771
[TBL] [Abstract][Full Text] [Related]
36. Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma.
Aldrich JD; Raghav KPS; Varadhachary GR; Wolff RA; Overman MJ
Oncologist; 2019 Jun; 24(6):e384-e386. PubMed ID: 30598498
[TBL] [Abstract][Full Text] [Related]
37. Empirical chemotherapy for adenocarcinoma of unknown primary tumor site.
Sporn JR; Greenberg BR
Semin Oncol; 1993 Jun; 20(3):261-7. PubMed ID: 7684858
[TBL] [Abstract][Full Text] [Related]
38. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
Trikudanathan G; Dasanu CA
Expert Opin Pharmacother; 2010 Jul; 11(10):1695-704. PubMed ID: 20446863
[TBL] [Abstract][Full Text] [Related]
39. [A rare cancer: cancers of the small intestine. 25 cases diagnosed at the Institut Pasteur de Madagascar from 1992 to 2001].
Raharisolo Vololonantenaina CR; Dina TJ; Ravalisoa A
Arch Inst Pasteur Madagascar; 2003; 69(1-2):82-6. PubMed ID: 15678822
[TBL] [Abstract][Full Text] [Related]
40. Small bowel adenocarcinoma metastatic to the ovaries in a 12-year-old girl.
Dunsmore KP; Lovell MA
J Pediatr Hematol Oncol; 1998; 20(5):498-501. PubMed ID: 9787329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
